Alterna Wealth Management’s Gilead Sciences GILD Stock Holding History

Alterna Wealth Management’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	$759K	Sell	13,033 -1,532	-11%	-$92.4K	0.96%	34
2020 Q3	$920K	Sell	14,565 -815	-5%	-$56.5K	1.33%	25
2020 Q2	$1.18M	Sell	15,380 -1,100	-7%	-$84.3K	1.41%	21
2020 Q1	$1.23M	Sell	16,480 -4,828	-23%	-$334K	1.78%	20
2019 Q4	$1.39M	Sell	21,308 -500	-2%	-$32.6K	1.54%	20
2019 Q3	$1.38M	Sell	21,808 -3,101	-12%	-$203K	1.63%	19
2019 Q2	$1.68M	Sell	24,909 -24,431	-50%	-$1.61M	2.02%	17
2019 Q1	$3.21M	Sell	49,340 -7,827	-14%	-$520K	2.71%	7
2018 Q4	$3.65M	Buy	+57,167	New	+$4M	0.6%	24

Other funds holding GILD

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Alterna Wealth Management's GILD Position: Q4 2020 in Review

Alterna Wealth Management reduced its Gilead Sciences (GILD) stake by 11% in Q4 2020, selling an estimated $92.4K and leaving 13,033 shares worth $759K. The position accounts for 0.96% of the portfolio, ranked #34.

Alterna Wealth Management first reported a position in GILD in Q4 2018 and has held it in 9 quarters since. The position peaked at $3.65M in Q4 2018. 1,563 funds tracked by Wall St. Rank hold GILD as of Q4 2020.

Alterna Wealth Management held 13,033 shares of Gilead Sciences worth $759K as of Q4 2020.
Alterna Wealth Management sold 1,532 Gilead Sciences shares in Q4 2020, an estimated $92.4K.
Gilead Sciences made up 0.96% of Alterna Wealth Management's portfolio in Q4 2020, its #34 holding.
Alterna Wealth Management first reported a position in Gilead Sciences in Q4 2018 and has held it in 9 quarters since.
Alterna Wealth Management's Gilead Sciences position peaked at $3.65M in Q4 2018.
1,563 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2020.

Based on Alterna Wealth Management's 13F filing for Q4 2020, filed 11 Feb 2021.